4YJS | THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000226 | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Somers, D.O. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.22 | ||||||||||||
ligand | 4DN | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor., Liddle J, Atkinson FL, Barker MD, Carter PS, Curtis NR, Davis RP, Douault C, Dickson MC, Elwes D, Garton NS, Gray M, Hayhow TG, Hobbs CI, Jones E, Leach S, Leavens K, Lewis HD, McCleary S, Neu M, Patel VK, Preston AG, Ramirez-Molina C, Shipley TJ, Skone PA, Smithers N, Somers DO, Walker AL, Watson RJ, Weingarten GG, Bioorg Med Chem Lett. 2011 Aug 12. PMID:21903390 |
Data retrieval |
View 4YJS in 3D |
Visual 3D analysis of 4YJS |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4YJS |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |